Pulmonary hypertension

A Mocumbi, M Humbert, A Saxena, ZC Jing… - Nature Reviews …, 2024 - nature.com
Pulmonary hypertension encompasses a range of conditions directly or indirectly leading to
elevated pressures within the pulmonary arteries. Five main groups of pulmonary …

Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine

KJ Dunham-Snary, D Wu, EA Sykes, A Thakrar… - Chest, 2017 - Elsevier
Hypoxic pulmonary vasoconstriction (HPV) is a homeostatic mechanism that is intrinsic to
the pulmonary vasculature. Intrapulmonary arteries constrict in response to alveolar hypoxia …

Mitochondrial dynamics—mitochondrial fission and fusion in human diseases

SL Archer - New England Journal of Medicine, 2013 - Mass Medical Soc
Mitochondria fuse and divide in response to cell demands and environment. Alterations in
mitochondrial dynamics underlie various human diseases, including cancer and neurologic …

[HTML][HTML] Intelligent polymeric hydrogen sulfide delivery systems for therapeutic applications

F Rong, T Wang, Q Zhou, H Peng, J Yang, Q Fan, P Li - Bioactive Materials, 2023 - Elsevier
Hydrogen sulfide (H 2 S) plays an important role in regulating various pathological
processes such as protecting mammalian cell from harmful injuries, promoting tissue …

Relevant issues in the pathology and pathobiology of pulmonary hypertension

RM Tuder, SL Archer, P Dorfmüller, SC Erzurum… - Journal of the American …, 2013 - jacc.org
Knowledge of the pathobiology of pulmonary hypertension (PH) continues to accelerate.
However, fundamental gaps remain in our understanding of the underlying pathological …

Pulmonary arterial hypertension: the clinical syndrome

YC Lai, KC Potoka, HC Champion, AL Mora… - Circulation …, 2014 - Am Heart Assoc
Pulmonary arterial hypertension is a progressive disorder in which endothelial dysfunction
and vascular remodeling obstruct small pulmonary arteries, resulting in increased …

Pulmonary vascular remodeling in pulmonary hypertension

RM Tuder - Cell and tissue research, 2017 - Springer
Pulmonary vascular remodeling is the key structural alteration in pulmonary hypertension
and involves changes in the intima, media and adventitia, often with the interplay of …

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

M Humbert, EMT Lau, D Montani, X Jaïs, O Sitbon… - Circulation, 2014 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is a disease characterized by progressive
remodeling of the distal pulmonary arteries, resulting in the loss of vascular cross-sectional …

MicroRNA-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension

L Deng, FJ Blanco, H Stevens, R Lu… - Circulation …, 2015 - Am Heart Assoc
Rationale: The pathogenesis of pulmonary arterial hypertension (PAH) remains unclear. The
4 microRNAs representing the miR-143 and miR-145 stem loops are genomically clustered …

Genetics and genomics of pulmonary arterial hypertension

F Soubrier, WK Chung, R Machado, E Grünig… - Journal of the American …, 2013 - jacc.org
Major discoveries have been obtained within the last decade in the field of hereditary
predisposition to pulmonary arterial hypertension (PAH). Among them, the identification of …